Estimate of maintenance EPO to darbepoetin
alfa dose conversion ratio in a hospital-based
dialysis patient population
The objective is to describe dose conversion methods that take into account the non-proportional dose relationship between EPO and darbepoetin alfa,
and calculate the dose conversion ratio (DCR) between the two ESAs in a hospital-based dialysis patient population.
Clinical trial data indicate that the relationship between EPO and darbepoetin alfa is non-proportional (non-linear) across the dosing spectrum;
darbepoetin alfa is more efficient with increasing EPO doses.
This non-proportional dose relationship is recognized in the dose conversion table included in the darbepoetin alfa U.S. package insert.
Clicca per scaricare la Patch per rilevare i dati del consumo ESA